Difficulty: Medium
Average Score: 76%
Practice
Tumor lysis syndrome is a common complication during treatment of pediatric malignancies. Which malignancy is more likely to manifest such complication?
Correct answer
D
Rationale
Tumor lysis syndrome (TLS) is a potentially life-threatening complication that can occur during the treatment of pediatric malignancies. It is characterized by metabolic disturbances such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia resulting from the rapid breakdown of tumor cells. In this scenario, Burkitt lymphoma is more likely to manifest TLS compared to the other malignancies listed.
Burkitt lymphoma is a highly proliferative B-cell non-Hodgkin lymphoma that is very sensitive to chemotherapy. The rapid cell turnover in Burkitt lymphoma leads to a higher risk of TLS due to the release of intracellular contents into the bloodstream during treatment initiation.
Acute myelogenous leukemia (AML) is associated with a high tumor burden but does not typically cause the same degree of rapid cell lysis seen in Burkitt lymphoma. Nephroblastoma (Wilms tumor) and neuroblastoma are pediatric solid tumors that, although they can be large, are less likely to lead to TLS compared to highly proliferative hematologic malignancies like Burkitt lymphoma.
Educationally, understanding the risk factors and manifestations of TLS in pediatric oncology is crucial for nurses caring for children with cancer. Recognizing the signs and symptoms of TLS, monitoring laboratory values closely, and implementing preventive measures are essential in the management of pediatric patients at risk for this serious complication.
Burkitt lymphoma is a highly proliferative B-cell non-Hodgkin lymphoma that is very sensitive to chemotherapy. The rapid cell turnover in Burkitt lymphoma leads to a higher risk of TLS due to the release of intracellular contents into the bloodstream during treatment initiation.
Acute myelogenous leukemia (AML) is associated with a high tumor burden but does not typically cause the same degree of rapid cell lysis seen in Burkitt lymphoma. Nephroblastoma (Wilms tumor) and neuroblastoma are pediatric solid tumors that, although they can be large, are less likely to lead to TLS compared to highly proliferative hematologic malignancies like Burkitt lymphoma.
Educationally, understanding the risk factors and manifestations of TLS in pediatric oncology is crucial for nurses caring for children with cancer. Recognizing the signs and symptoms of TLS, monitoring laboratory values closely, and implementing preventive measures are essential in the management of pediatric patients at risk for this serious complication.